Overview
The registry study aims to discover biomarkers for accurate classification and risk assessment of ischemic heart disease.
Description
The purpose of this study is to discover biomarkers for early identification, diagnosis, molecular classification, and intervention based on the mechanism of ischemic heart disease（IHD）. Using mass spectrometry-based metabolomics and multimodal imaging technology, the study aims to further construct a new system for early risk stratification of IHD based on abnormal metabolites.
Eligibility
Inclusion criteria :
- Aged 18 years or older.
- Previous ischemic symptoms/signs or electrocardiographic ischemic changes and.
- >70% stenosis of at least one epicardial coronary artery on angiography or a history of myocardial infarction or coronary revascularization.
Exclusion Criteria:
- Current known inability to follow instructions or comply with follow-up procedures.
- Eligible patients without informed consent form